Introduction
Interallelic complementation is defined as the ability of two differentially mutated alleles to function better together than either can on its own. Despite its near universality in lower organisms [1] , its potential to contribute to clinical heterogeneity in human disease is seldom considered. Evidence of interallelic complementation at clinically relevant loci is limited to biochemical and cell-based studies of a handful of metabolic disorders with defects in enzymes including propinyl-CoA carboxylase [2] , argininosuccinate lyase [3] , galactose-1-phosphate uridylyltransferase [4] , and methylmalonyl CoA mutase [5] .
Compound heterozygotes are individuals carrying two different mutant alleles of the same gene. In the absence of a dominant (wild-type [wt]) allele, genetic interactions between recessive alleles (referred to here as ''biallelic'' effects) could result in different phenotypic outcomes including interallelic complementation. Although amelioration of disease symptoms by interallelic complementation would create an ascertainment bias in the clinic, the lack of evidence concerning interallelic complementation or other biallelic effects in human disease is likely caused by the difficulty in distinguishing such effects from environment and genetic background.
XPD encodes one of the two helicase components of basal transcription/DNA repair factor IIH (TFIIH), a ten-subunit, multifunctional complex that is essential for multiple processes, including basal transcription initiation and DNA damage repair via the nucleotide excision repair (NER) pathway [6, 7] . Alterations in XPD resulting in defective TFIIH function are associated with UV-sensitive, multisystem disorders including xeroderma pigmentosum (XP), XP combined with Cockayne syndrome (CS), and trichothiodystrophy (TTD) [8] [9] [10] . XP is marked by sun-induced pigmentation anomalies and a greater than 1,000-fold elevation in skin cancer risk. Severe cases can also present with growth retardation and primary neurodegeneration [11] . CS and TTD, on the other hand, are segmental progeroid disorders characterised by progressive post-natal growth failure and primary demyelination resulting in severe neurodysfunction, but without a clear cancer predisposition [12] [13] [14] [15] . Patients with TTD additionally display hallmark sulphur-deficient brittle hair and nails and scaling skin [13] , resulting from a basal transcription defect in specific cell types [16, 17] . A related disorder with the cancer predisposition of XP combined with the neurodevelopmental complications of CS (XPCS), although rare, has also been described [18] .
Many XPD mutations are associated with an exclusive disease phenotype (e.g., XPD R722W with TTD and XPD
R683W
with XP) and are thus viewed as causative of the corresponding syndromes. Alleles not associated exclusively with one disorder are considered ''likely null'' alleles [19, 20] . Some of these alleles fail to support viability in a haploid Schizosaccharomyces pombe yeast strain with a null mutation in the XPD homologue rad15 and are thus considered devoid of significant biological activity [19] . This classification of alleles as either causative or null currently defines what we refer to as a ''monoallelic'' paradigm of XPD disease. However, the identification in recent years of XP complementation group D patients with atypical disease presentation, including symptoms of both XP and TTD [8] , casts doubt on the ability of such a monoallelic paradigm to explain clinical heterogeneity in compound heterozygotes. Previously, we generated a TTD mouse model (XPD R722W ) that phenocopies the human syndrome [15, 21] . Here we report the generation of additional mutant Xpd alleles that fail to support viability on their own but nevertheless ameliorate TTD-associated premature segmental ageing, cutaneous features, cellular DNA repair capacity, and UV survival when present in a compound heterozygote state.
Results

Generation of Xpd Compound Heterozygotes
We generated an Xpd knock-in allele with a point mutation encoding a single amino acid change (XPD G602D ) found in the XPCS patient XPCS2 ( Figure 1A-1C) . mRNA expression from the targeted allele could be detected in embryonic stem cells by RT-PCR ( Figure 1D ), although expression was reduced approximately 5-fold relative to wt mRNA transcript levels as determined by Northern blotting of RNA from the testis of heterozygous animals ( Figure 1E ). Because patient XPCS2 was a hemizygote with mutant XPD protein (XPD G602D ) expressed from a single allele, the corresponding mutation was expected to be viable in the homozygous state. However, homozygous mutant mice were not observed, neither amongst live births nor embryonic day 13.5 (E13.5) or E3.5 embryos ( Table 1) . The corresponding hypomorphic, mutant allele was thus designated as homozygous lethal ( XPCS). Homozygous lethality of the XPCS allele is likely due to reduced levels of expression of this essential protein as a result of gene targeting ( Figure 1A ) rather than to the mutation itself. Xpd ablation (Xpd KO/KO ) is similarly incompatible with life beyond the earliest stages of embryogenesis [22] . Consistent with this interpretation, a different targeted Xpd mutation encoding XPD R683W , which is associated with XP in the homozygous state in humans, was similarly underexpressed and lethal in the homozygous state (designated as XP allele) (Figure 1A-1C Figure 1E ). Because of a lack of available antibodies and the inability to distinguish amongst various mutant forms of XPD differing only by single amino acid substitutions, we were unable to ascertain the relative amount of XPD protein from the different alleles.
Despite reduced levels of mRNA expression, the homozygous lethal Xpd XPCS allele ameliorated multiple Xpd TTD -associated disease symptoms in compound heterozygous Xpd TTD/ XPCS animals including the hallmark brittle hair and cutaneous features fully penetrant in homo-and hemizygous TTD mice (Figure 2A-2C) . In marked contrast to Xpd TTD/TTD (and Xpd TTD/KO ) mice, which display complete hair loss in the first hair cycle and partial hair loss in subsequent cycles throughout their lives [21] , compound heterozygous Xpd TTD/ XPCS mice displayed some hair loss only during the first hair cycle and only locally at the back (Figure 2A) . Scanning electron microscope analysis of Xpd TTD/ XPCS hair revealed an almost normal appearance, with TTD-like features such as broken hairs found only at very low frequency (unpublished data). Amino acid analysis confirmed that cysteine levels in the hair of the Xpd TTD/ XPCS mice were significantly higher than in Xpd TTD/TTD animals, but remained below the wt level ( Figure 2C ). TTD hemizygotes (Xpd TTD/KO ) do not display significant differences in cutaneous features and longevity relative to homozygous Xpd TTD/TTD mice [21] . Other prominent TTD features in the epidermis, including acanthosis (thickening of the layer of the nucleated cells), hyperkeratosis (prominent thickening of the cornified layer), and pronounced granular layer and sebacious gland hyperplasia (causing greasy appearance of the hair), were absent in the skin of Xpd TTD/ XPCS mice, as established by blind microscopic examination of skin sections ( Figure 2B ). Furthermore, anaemia and developmental delay present in patients with TTD [24] and in Xpd TTD/TTD mice [15] were both partially rescued in compound heterozygous Xpd TTD/ XPCS mice ( Figure  2D and 2E).
Rescue of Progeroid Features in TTD Mice by Homozygous Lethal Xpd Alleles
Because patients with TTD, XPCS, and CS (but not XP) and the corresponding mouse models share similar accelerated progeroid symptoms [12, 13, 15, 23] , we next addressed ageingrelated parameters in compound heterozygous mice ( Figure 3 ). Whereas Xpd TTD/TTD animals show reduced bone mineral density as an indication of the early onset of osteoporosis before ;14 mo of age [15] , tail vertebrae from compound heterozygous Xpd TTD/ XPCS mice were comparable to wt even at 20 mo of age ( Figure 3B and 3C). Furthermore, whereas Xpd TTD/TTD mice developed kyphosis earlier than wt animals (onset ;3 mo versus 12-20 mo), compound heterozygous Xpd TTD/ XPCS mice did not ( Figure 3B ). Overall appearance and body weight curves revealed that TTD-associated age-related premature cachexia and lack of general fitness were fully rescued in compound heterozygous Xpd TTD/ XPCS mice ( Figure 3A and 3D). Finally, the life span of compound heterozygotes was extended relative to Xpd TTD/TTD mice ( Table 2) .
To determine whether the homozygous lethal Xpd XPCS allele was unique in its ability to ameliorate symptoms associated with the Xpd TTD allele, we generated compound heterozygous Xpd TTD/ XP mice by crossing the corresponding heterozygous animals. Similar to the Xpd XPCS allele, the homozygous lethal Xpd XP allele rescued cutaneous symptoms including hair loss (except locally during the first round; unpublished data), reduced cysteine content (cysteine index 9.3 6 0.9 standard deviation [87% of wt], p ¼ 0.01 versus TTD), ageing-associated premature cachexia (males and females were 36.1 6 6.4 g [93% of wt] and 39.2 6 3.2 g [116% of wt], respectively), and reduced life span (Table 2) . Taken together, these data indicate that two independent alleles, which on their own are unable to support viability (Table 1) , were nonetheless able to ameliorate TTD-associated phenotypes in vivo ( Table 2 ).
Molecular Mechanisms of Biallelic Effects
We next turned to UV-based cellular assays including unscheduled DNA synthesis after UV irradiation (UV-UDS), recovery of RNA synthesis after UV irradiation (UV-RRS), and UV survival, which report on the NER subpathways (global genome NER and transcriptioncoupled NER) and total NER, respectively. In none of these assays was the response to UV improved in compound heterozygotes relative to TTD homozygotes ( Figure 4A-4C Figure 4A ). Because of Figure 4D ). Taken together, these data are consistent with interallelic complementation of UV sensitivity in cells but underscore the lack of any correlation between UV-related repair characteristics and TTD progeroid phenotypes in animal models. Next we asked whether the Xpd XPCS and Xpd XP alleles, despite decreased mRNA levels, ameliorated TTD symptoms by increasing overall TFIIH levels in compound heterozygous Xpd TTD/ XPCS and Xpd TTD/ XP cells. Previously, using comparative immunohistochemistry, we and others have shown an up to 70% reduction of TFIIH levels in primary fibroblasts from patients with TTD compared with wt controls due to reduced stability [16, 17] . Despite overexpression of mRNA from the Xpd TTD allele relative to the wt allele ( Figure 1E ), TFIIH protein levels were reduced by 50% in primary mouse Xpd TTD/TTD fibroblasts ( Figure 4E and 4F) , thereby mimicking the situation in human patients with TTD. In accordance with the gene dosage, a further reduction of up to 70% of the wt level was observed in hemizygous Xpd TTD/KO cells. Consistent with low mRNA expression levels, neither the Xpd XPCS nor the Xpd XP allele was able to restore TFIIH abundance to wt levels in Xpd TTD compound heterozygote cells ( Figure 4E and  4F) . Thus, the improved UV survival observed in compound heterozygote cells ( Figure 4A ) and likely the rescue of TTD progeroid symptoms ( Figure 3) were not due to normalisation of TFIIH levels, suggesting a qualitative rather than a quantitative effect on these phenotypes in vivo.
In contrast, the level of XPCS mRNA expression did affect the ability of the encoded protein (XPD G602D ) to restore the TTD hair phenotype to normal. Notably, Xpd TTD/ XPCS animals had a partial TTD hair phenotype, correlating with low levels of Xpd XPCS expression, whereas Xpd TTD/XPCS animals had wt hair, correlating with normal expression levels from the viable Xpd XPCS allele (Table 2 and unpublished data). Thus, the range of expression levels from these two mutant alleles affected their ability to complement some phenotypes (hair). An overview of the functional relationships between Xpd alleles, phenotypes, and the presumed underlying TFIIH function in mice and cells is presented in Table 2 .
Discussion
Dissection of Biallelic Effects from other Determinants of Phenotype
Although phenotypic consequences, referred to here as biallelic effects, resulting from two different mutant alleles in compound heterozygote patients have been postulated, such effects have historically been difficult to distinguish from the influence of environment and genetic background. We used a genetically defined mammalian model system under controlled environmental conditions to reveal phenotypic effects attributable specifically to combinations of differentially mutated Xpd alleles.
The observed biallelic effects were of three general types. In the first, the allele associated in a homozygous state with a phenotype closer to wt singularly determined the In the 129Ola/C57BL6 mixed genetic background used in a previous study [15] , the average life span of Xpd TTD/TTD mice was approximately 12 mo. Nevertheless, three out of six Xpd TTD/TTD mice included in this study lived until 19-20 mo, although their overall appearance was poor at the time they were killed ( Figure 3A) . Xpd TTD/ XPCS mice (n ¼ 8) reached the age of 19-20 mo and were in a good condition at the time they were killed ( Figure 3A) . Two Xpd TTD/ XPCS animals not killed died at 24 and 26 mo of age, which is in the wt range. Similar condition and life span extension were observed in Xpd TTD/ XP mice (n ¼ 6) killed at the age of 19-20 mo for analysis. Xpd XPCS/XPCS mice had a mean life span of ;18 mo that was significantly shorter than controls (;21 mo, log rank p ¼ 0.001; [23] phenotypic outcome, a phenomenon widely known in human recessive disease. Because these Xpd alleles functioned at or near wt levels with respect to a particular function, we call these effects ''dominant''. Such alleles can also be referred to as ''separation of function'' alleles, because they allow dissection of the roles of multifunctional proteins in specific phenotypes.
Secondly, highlighting the potential relevance of current findings to all diploid organisms including humans was the observation that in one compound heterozygous animal, the Xpd allelic relationship could shift from A dominant ja recessive to A recessive ja dominant with respect to different phenotypes in a time-dependent and tissue-specific manner (see below and Table 2 ).
In the third type of biallelic effect, known as interallelic complementation, two mutant alleles produced a phenotype closer to wt than either could alone in a homo-or hemizygous state. As summarised in Table 2 , examples of all types of biallelic effects were observed in a variety of Xpd-associated phenotypes, ranging from brittle hair to segmental progeria. Table 2) .
TTD-specific cutaneous and anaemic features, on the other hand, are thought to result from a specific kind of transcriptional insufficiency caused by depletion of unstable TFIIH during the terminal differentiation of skin, hair-shaft, and blood cells [16, 24] . In compound heterozygous mice, both homozygous lethal Xpd XPCS and Xpd XP alleles were able to alleviate Xpd TTD -specific cutaneous and anaemic features and can thus be defined as dominant over the Xpd TTD allele with respect to these phenotypes. We conclude that the defects leading to embryonic lethality and aberrant terminal differentiation of the skin, hair, and blood represent two qualitatively and/or quantitatively different transcriptional deficiencies. During early embryonic development, Xpd TTD is dominant over the Xpd XPCS and Xpd XP alleles, whereas later in the ontogenesis of skin, hair-shaft, and blood cells, the situation is reversed.
In its role in the repair of UV photolesions, the Xpd XPCS allele imparted a clear UV survival benefit over a single Xpd TTD allele or two Xpd XPCS alleles independent of expression levels, which is consistent with interallelic complementation. However, the observation that no other cellular or biochemical UVrelated parameters were improved in Xpd TTD/ XPCS argues against complementation of this repair activity in the rescue of TTD progeroid symptoms in vivo.
Interallelic Complementation and XPD Function
What does interallelic complementation tell us about the mechanism of XPD function? Interallelic complementation is most often observed in multimeric proteins with multiple functional domains. Unfortunately, the structure-function relationship between disease-causing mutations and XPD functional domains, including detailed structural information on XPD or even its stoichiometry within TFIIH, remains unknown. However, based on the ability of cell extracts that are defective in two different TFIIH components (XPD and XPB) to complement NER activity in vitro [26] , it is likely that TFIIH (or its components) can either multimerise or exchange at least during the NER reaction. Furthermore, XPD is known to be a ''loosely bound'' subunit of TFIIH [27] . We thus envisage the molecular mechanism of interallelic complementation to involve the exchange of XPD molecules within the TFIIH complex or turnover of TFIIH complexes containing different XPD molecules at the site of DNA damage during the course of the global genome as well as transcription-coupled repair of either UV-induced or endogenous DNA damage.
A Biallelic Paradigm for XPD Disorders
Recently, proteins originating from presumed null alleles were biochemically characterised as inactive in basal transcription [27] , providing an explanation as to why these alleles failed to rescue lethality in haploid S. pombe with a null mutation in the XPD homologue rad15 [19] . Our data suggest that certain presumed null alleles, although unable on their own to support basal transcription, may in fact have a substantial impact on disease outcome in compound heterozygous humans, as they do in mouse models.
Clinical evidence in support of this hypothesis comes from a number of XP complementation group D patients that do Figure 5 . Genotype-Phenotype Relationships in XPD Disorders According to the current monoallelic hypothesis, phenotype is determined solely by the causative allele product. If a second, different allele is present, it is considered a functional null. There is a lack of any correlation between the site of the XPD mutation and the resulting disorder. We propose a biallelic hypothesis for compound heterozygotes in which both alleles can contribute to the phenotype. Examples of compound heterozygous patients in which a second, presumed null allele is likely to contribute to disease outcome are provided above in comparison to corresponding homo-or hemizygous patients with the same causative allele. Numbers in the schematic of the protein indicate the helicase domains. DOI: 10.1371/journal.pbio.0040322.g005 not fit within the framework of the current monoallelic paradigm of XPD disorders ( Figure 5) . In contrast to two hemizygous XPD XPCS patients carrying the XPD G47R -or XPD R666W -encoding alleles who died of the disease before 2 y of age, two compound heterozygous XPD XPCS patients carrying the same XPD G47R -or XPD R666W -encoding alleles in addition to the presumed null XPD L461Vþdel716À730 both had considerably milder disease symptoms and survived more than ten times longer (A. Lehmann, personal communication) ( Figure 5 ). Compound heterozygosity is also associated with the recently reported combination XP and TTD (XPTTD) syndrome [8] . Similar to the Xpd TTD/ XPCS and Xpd TTD/ XP mice described here, both patients with XPTTD described so far had intermediate hair cysteine values. Furthermore, XPTTD patient XP38BR carried a ''causative'' TTD mutation in one allele and a novel point mutation encoding XPD L485P in the other. Although the XPD L485P -encoding allele fails to complement viability in the haploid S. pombe rad15 deletion strain and is thus interpretable as a null allele [8] , we nonetheless suggest that the combined XPTTD phenotype in this patient involves phenotypic contributions from both alleles. Taken together, these data suggest a shift to a biallelic paradigm for compound heterozygous patients in XP complementation group D.
Potential of Combined Recessive Alleles to Affect Phenotypic Diversity in Mammals
In humans, the clinical relevance of biallelic effects such as interallelic complementation remains unknown. Although interallelic complementation between two endogenous mutant alleles has been described in cells from a compound heterozygous patient with methylmalonic acidaemia, no observable effects on disease outcome were noted in the patient [28] . Thus, to the best of our knowledge, the amelioration of progeroid features observed here is the first in vivo demonstration in compound heterozygous animals of interallelic complementation relevant to a human disease. Keeping in mind that the ;1,200 alleles known to exist for the CTRF gene implicated in the common autosomal recessive disorder cystic fibrosis alone [29] can theoretically result in ;700,000 different allelic combinations, the potential number of allelic combinations of different recessive mutations and single nucleotide polymorphisms genome-wide is currently incalculable. We suggest biallelic effects as a previously underestimated yet important variable in considering genotype-phenotype relationships from autosomal recessive disease to normal phenotypic diversity in mammals. Extension of the above concept implies that recessive mutations can enter evolutionary selection in F1 provided that the second allele carries a different recessive alteration. Finally, our data highlight the potential of clinically relevant alleles previously designated as null, with little or no detectable expression or activity, to nonetheless contribute to phenotype.
Materials and Methods
Derivation and analysis of mutant mice. Generation of Xpd TTD (XPD R722W ) and Xpd TTD/KO mice has been described previously [21, 22] . A detailed description of the generation of targeting constructs for Xpd XPCS and Xpd XP alleles carrying mutations encoding the G602D and R683W alterations will be provided upon request. Chimeric mice and mouse embryonic fibroblasts were generated according to standard procedures. Haematoxylin and eosin staining was performed according to standard procedures. Amino acid analysis was conducted as described in [21] . Blood values were analysed using Animal Blood Counter Vet (ABX Diagnostix, Montpellier, France). Radiographs were taken, and relative bone mineral density was calculated as described in [15] . Mice used in this study were in a 129Ola/C57BL6 mixed background unless noted differently. All experiments involving mice were judged and approved by the national committee for genetic identification of organisms and the animal ethical committee, and were conducted according to national and international guidelines.
UV sensitivity, UV-UDS, UV-RRS, and TFIIH incision/excision activity. UV survival, UV-UDS, and UV-RRS assays were performed as described previously [21, 30] . For UV-RRS, average values from the representative experiment containing two wt, three Xpd TTD/TTD , two Xpd TTD/XPCS , and one Xpd TTD/XP cell line are presented. The ;48% UV-UDS value presented in this study for Xpd TTD/TTD cells differs from our previously published data of 25% UV-UDS [21] , possibly because of the high variability intrinsic to the assay or routine variations in the cell culture conditions. For the incision/ excision activity assay, recombinant TFIIH was prepared and assayed as described previously [27] .
Comparative immunofluorescence. Latex bead labelling and comparative immunofluorescence analysis of the p62 subunit of the TFIIH was performed as described previously [16, 17] using primary mouse embryonic fibroblasts at passages 2-5. Two or more cell lines per genotype (except for the Xpd TTD/ XP cells, in which only one cell line was used in repeated experiments) were used, and experiments were repeated 2-6 times per genotype.
